The effects of ursodeoxycholic acid on albuminuria in people with type 1 diabetes and diabetic kidney disease: a proof-of-concept study
This first-ever human study investigating the potential renoprotective effect of UDCA treatment for 24 weeks in people with type 1 diabetes and DKD did not observe a significant reduction in urine albumin excretion rate (UAER).